日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting the risk for distant metastasis in hypopharyngeal squamous cell carcinoma and assessing the survival benefit of induction therapy

预测下咽鳞状细胞癌远处转移的风险并评估诱导治疗的生存获益

Zhang, Yu; Wang, Junsong; Zhao, Wanying; Yang, Ping; Jiang, Xin; Tang, Jinhai; Zhang, Huimin; Chen, Tongtong; Wang, Jie; Lv, Xiupeng

[Retracted] Improved ataxia telangiectasia mutated kinase inhibitor KU60019 provides a promising treatment strategy for non-invasive breast cancer

【已撤稿】改良型共济失调毛细血管扩张症突变激酶抑制剂KU60019为非侵袭性乳腺癌提供了一种有前景的治疗策略

Zhu, Ying; Mao, Changfei; Wu, Jianzhong; Li, Shuchun; Ma, Rong; Cao, Haixia; Ji, Minghua; Jing, Changwen; Tang, Jinhai

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarker

全面的泛癌分析发现SLC16A3是一种潜在的预后和诊断生物标志物。

Yang, Ping; Yin, Jiayu; Zhang, Gongyin; Li, Xiaofeng; Chen, Tongtong; Zhao, Wanying; Tang, Jinhai; Lv, Li; Lv, Xiupeng

Sacituzumab govitecan in HR(+)HER2(-) metastatic breast cancer: the randomized phase 3 EVER-132-002 trial

Sacituzumab govitecan 治疗 HR(+)HER2(-) 转移性乳腺癌:随机 3 期 EVER-132-002 试验

Xu, Binghe; Wang, Shusen; Yan, Min; Sohn, Joohyuk; Li, Wei; Tang, Jinhai; Wang, Xiaojia; Wang, Ying; Im, Seock-Ah; Jiang, Dongdong; Valdez, Theresa; Dasgupta, Anandaroop; Zhang, Yiran; Yan, Yilin; Komatsubara, Kimberly M; Chung, Wei-Pang; Ma, Fei; Dai, Ming-Shen

Efficacy, Safety, and Population Pharmacokinetics of MW032 Compared With Denosumab for Solid Tumor-Related Bone Metastases: A Randomized, Double-Blind, Phase 3 Equivalence Trial

MW032 与地诺单抗治疗实体瘤相关骨转移的疗效、安全性和群体药代动力学比较:一项随机、双盲、3期等效性试验

Zhang, Shaohua; Yin, Yongmei; Xiong, Hailin; Wang, Jingfen; Liu, Hu; Lu, Junguo; Zhang, Qingyuan; Zhang, Longzhen; Zhong, Jincai; Nie, Jianyun; Lei, Kaijian; Wang, Hong; Yang, Shu; Yao, Herui; Wu, Huijing; Yu, Ding; Ji, Xuening; Zhang, Hua; Wu, Fang; Xie, Weimin; Li, Wei; Yao, Weirong; Zhong, Diansheng; Sun, Hongmei; Sun, Tao; Guo, Zengqing; Wang, Rui; Guo, Yanzhen; Yu, Zhuang; Li, Dairong; Jin, Hongyan; Song, Haifeng; Chen, Xiaoyuan; Ma, Wen; Hu, Zhitian; Liu, Datao; Guo, Yinhan; Tang, Jinhai; Jiang, Zefei

Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study

阿贝西利联合内分泌治疗作为激素受体阳性、HER2阴性、高危早期乳腺癌的辅助治疗:一项III期随机monarchE研究的5年中国人群分析

Zhang, Qingyuan; Shen, Kunwei; Song, Chuan-Gui; Ouyang, Quchang; Liu, Zhenzhen; Liu, Qiang; Feng, Jifeng; Chiu, Joanne W Y; Tang, Jinhai; Jiang, Zefei; Tseng, Ling-Ming; Wang, Xiaojia; Yang, Liu; Qian, Chenxi; Shao, Zhimin

The relationship between prognosis and temporal muscle thickness in 102 patients with glioblastoma

102例胶质母细胞瘤患者的预后与颞肌厚度的关系

Tang, Jinhai; Dong, Zhenghao; Yang, Lei; Yang, Ping; Zhao, Wanying; Deng, Lvdan; Xue, Juan; Cui, Yijie; Li, Qizheng; Tang, Lufan; Sheng, Junxiu; Zhang, Yu; Zhang, Huimin; Chen, Tongtong; Dong, Bin; Lv, Xiupeng

HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and migration

HJURP通过促进细胞增殖和迁移,预示着女性乳腺癌预后不良。

Chen, Wenquan; Li, Hao; Wang, Dandan; Yang, Sujin; Hou, Junchen; Zhou, Honglei; Tang, Jinhai; Zhang, Jian

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer.

RelB 激活的 GPX4 抑制铁死亡,并赋予乳腺癌细胞他莫昔芬耐药性

Xu Zhi, Wang Xiumei, Sun Wenbo, Xu Fan, Kou Hengyuan, Hu Weizi, Zhang Yanyan, Jiang Qin, Tang Jinhai, Xu Yong

Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review

颞肌厚度与胶质母细胞瘤患者预后关系的研究进展:叙述性综述

Tang, Jinhai; Dong, Zhenghao; Sheng, Junxiu; Yang, Ping; Zhao, Wanying; Xue, Juan; Li, Qizheng; Lv, Li; Lv, Xiupeng